September 23, 2020
Stricter Vaccine Approval Rules Coming From FDA
If approved by the White House, revised guidelines could be released as early as next week
WEDNESDAY, Sept. 23, 2020 (HealthDay News) -- Stricter guidelines for emergency use authorization of a vaccine against the new coronavirus could soon be issued by the U.S. Food and Drug Administration.
The guidelines would outline more specific criteria for clinical trial data and recommend the data be reviewed by a committee of independent experts before the FDA authorizes any vaccine, people familiar with the draft told The New York Times.
If approved by the White House, the revised guidelines could be released as early as next week.
The move to tighten the rules on emergency vaccine approval come as President Donald Trump keeps promising that a vaccine will be available as early as next month, The Times reported.
Physician's Briefing
Products
Language
English
News types
Institutional
Topics
Coronavirus
Food & Drug Administration
Vaccines
Specialties
Infectious Disease
Nursing
OBGYN & Women's Health
Pediatrics
Pulmonology
Internal Medicine
Critical Care
Emergency Medicine
Pathology
Pharmacy
Physicians Briefing
